House Energy & Commerce Committee leaders are questioning FDA's policy of not routinely conducting good manufacturing practices inspections at facilities that use drugs solely for research purposes, as lawmakers step up their probe of the recent closure of a section of NIH's Clinical Center Pharmacy Department that manages investigational drugs. In letters sent on Friday (July 31), E&C Chair Fred Upton (MI) and Ranking Democrat Frank Pallone (NJ), joined by investigations subcommittee Chair Tim Murphy (PA) and Ranking Democrat Diana...